CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer

Elaine Sanij*, Katherine M. Hannan, Jiachen Xuan, Shunfei Yan, Jessica E. Ahern, Anna S. Trigos, Natalie Brajanovski, Jinbae Son, Keefe T. Chan, Olga Kondrashova, Elizabeth Lieschke, Matthew J. Wakefield, Daniel Frank, Sarah Ellis, Carleen Cullinane, Jian Kang, Gretchen Poortinga, Purba Nag, Andrew J. Deans, Kum Kum KhannaLinda Mileshkin, Grant A. McArthur, John Soong, Els M.J.J. Berns, Ross D. Hannan, Clare L. Scott, Karen E. Sheppard, Richard B. Pearson

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    95 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Biochemistry, Genetics and Molecular Biology